Skip to main content
Erschienen in: Wiener klinische Wochenschrift 23-24/2017

12.07.2017 | original article

Value of the neutrophil-to-lymphocyte ratio in predicting left ventricular recovery in patients with peripartum cardiomyopathy

verfasst von: Ufuk Gürkan, MD, Haldun Akgöz, MD, Şukru Aksoy, MD, Özlem Can Gürkan, PhD, Altug Osken, MD, Sennur Unal Dayi, MD, Dilaver Oz, MD, Recep Haci, MD

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 23-24/2017

Einloggen, um Zugang zu erhalten

Summary

Objective

The aim of this study was to assess the value of the neutrophil-to-lymphocyte ratio (NLR) in predicting left ventricular (LV) recovery in patients with peripartum cardiomyopathy (PPCM).

Methods

Patients with PPCM (n = 40), who were admitted to our tertiary reference hospital between 2007 and 2015 were retrospectively analyzed. All patients were followed-up for at least 12 months after the diagnosis. All patients had standard echocardiographic examination at baseline and the last follow-up visit. Recovery of LV function was defined as the presence of LV ejection fraction (EF) >45%. Data on blood parameters were also collected at baseline. Univariate and multivariate analysis were used to assess the significant predictive variables for persistent LV systolic dysfunction.

Results

Of the patients 21 (52.5%) did not recover LV function at the last follow-up visit (nonrecovery group), while 19 of the patients (47.5%) exhibited LV recovery (recovery group). The LV EF and fractional shortening (FS) were significantly lower in the nonrecovery group. The baseline LV end-diastolic diameter, LV end-systolic diameter (LVESD) and systolic pulmonary arterial pressure were significantly increased in the nonrecovery group. The NLR, C‑reactive protein and troponin levels were significantly higher in the nonrecovery group. In multivariate logistic regression analysis only NLR and LVESD were identified as independent predictors of persistent LV systolic dysfunction in patients with PPCM (p = 0.020 and p = 0.009 respectively).

Conclusion

Elevated NLR and increased LVESD were independent prognostic factors in predicting persistent LV dysfunction in patients with PPCM. The NLR might assist in identifying high risk patients with PPCM.
Literatur
1.
Zurück zum Zitat Sliwa K, Hilfiker-Kleiner D, Petrie MC, Mebazaa A, Pieske B, Buchmann E, et al. Current state of knowledge on aetiology, diagnosis, management and theraphy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail. 2010;12:767–78.CrossRefPubMed Sliwa K, Hilfiker-Kleiner D, Petrie MC, Mebazaa A, Pieske B, Buchmann E, et al. Current state of knowledge on aetiology, diagnosis, management and theraphy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail. 2010;12:767–78.CrossRefPubMed
2.
Zurück zum Zitat Pearson GD, Veille JC, Rahimtoola S, Hsia J, Oakley CM, Hosenpud JD, et al. Peripartum cardiomyopathy: National Heart, Lung and Blood Institute and Office of Rare Diseases (National Institutes of Health) Workshop recommendations and review. JAMA. 2000;283:1183–8.CrossRefPubMed Pearson GD, Veille JC, Rahimtoola S, Hsia J, Oakley CM, Hosenpud JD, et al. Peripartum cardiomyopathy: National Heart, Lung and Blood Institute and Office of Rare Diseases (National Institutes of Health) Workshop recommendations and review. JAMA. 2000;283:1183–8.CrossRefPubMed
3.
Zurück zum Zitat Mielniczuk LM, Williams K, Davis DR, Tang AS, Lemery R, Green MS, et al. Frequency of peripartum cardiomyopathy. Am J Cardiol. 2006;97:1765–8.CrossRefPubMed Mielniczuk LM, Williams K, Davis DR, Tang AS, Lemery R, Green MS, et al. Frequency of peripartum cardiomyopathy. Am J Cardiol. 2006;97:1765–8.CrossRefPubMed
4.
Zurück zum Zitat Brar SS, Khan SS, Sandhu GK, Jorgensen MB, Parikh N, Hsu JW, et al. Incidence, mortality and racial differences in peripartum cardiomyopathy. Am J Cardiol. 2007;100:302–4.CrossRefPubMed Brar SS, Khan SS, Sandhu GK, Jorgensen MB, Parikh N, Hsu JW, et al. Incidence, mortality and racial differences in peripartum cardiomyopathy. Am J Cardiol. 2007;100:302–4.CrossRefPubMed
5.
Zurück zum Zitat Fett JD, Christie LG, Carraway RD, Murphy JG. Five-year prospective study of the incidence and prognosis of peripartum cardiomyopathy at a single institution. Mayo Clin Proc. 2005;80:1602–6.CrossRefPubMed Fett JD, Christie LG, Carraway RD, Murphy JG. Five-year prospective study of the incidence and prognosis of peripartum cardiomyopathy at a single institution. Mayo Clin Proc. 2005;80:1602–6.CrossRefPubMed
6.
Zurück zum Zitat Chapa JB, Heiberger HB, Weinert L, Decara J, Lang RM, Hibbard JU. Prognostic value of echocardiography in peripartum cardiomyopathy. Obstet Gynecol. 2005;105:1303–8.CrossRefPubMed Chapa JB, Heiberger HB, Weinert L, Decara J, Lang RM, Hibbard JU. Prognostic value of echocardiography in peripartum cardiomyopathy. Obstet Gynecol. 2005;105:1303–8.CrossRefPubMed
8.
Zurück zum Zitat Nishimoto O, Matsuda M, Nakamoto K, et al. Peripartum cardiomyopathy presenting with syncope due to Torsades de pointes: a case of long QT syndrome with a novel KCNH2 mutation. Intern Med. 2012;51:461–4.CrossRefPubMed Nishimoto O, Matsuda M, Nakamoto K, et al. Peripartum cardiomyopathy presenting with syncope due to Torsades de pointes: a case of long QT syndrome with a novel KCNH2 mutation. Intern Med. 2012;51:461–4.CrossRefPubMed
9.
Zurück zum Zitat Dalzell JR, Jackson CE, Gardner RS. An update on peripartum cardiomyopathy. Expert Rev Cardiovasc Ther. 2011;9:1155–60.CrossRefPubMed Dalzell JR, Jackson CE, Gardner RS. An update on peripartum cardiomyopathy. Expert Rev Cardiovasc Ther. 2011;9:1155–60.CrossRefPubMed
10.
Zurück zum Zitat Goland S, Modi K, Bitar F, Janmohamed M, Mirocha JM, Czer LS, Illum S, Hatamizadeh P, Elkayam U. Clinical profile and predictors of complications in peripartum cardiomyopathy. J Card Fail. 2009;15(8):645–50.CrossRefPubMed Goland S, Modi K, Bitar F, Janmohamed M, Mirocha JM, Czer LS, Illum S, Hatamizadeh P, Elkayam U. Clinical profile and predictors of complications in peripartum cardiomyopathy. J Card Fail. 2009;15(8):645–50.CrossRefPubMed
11.
Zurück zum Zitat Haghikia A, Podewski E, Libhaber E, Labidi S, Fischer D, Roentgen P, Tsikas D, Jordan J, Lichtinghagen R, von Kaisenberg CS, Struman I, Bovy N, Sliwa K, Bauersachs J, Hilfiker-Kleiner D. Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy. Basic Res Cardiol. 2013;108(4):366.CrossRefPubMedPubMedCentral Haghikia A, Podewski E, Libhaber E, Labidi S, Fischer D, Roentgen P, Tsikas D, Jordan J, Lichtinghagen R, von Kaisenberg CS, Struman I, Bovy N, Sliwa K, Bauersachs J, Hilfiker-Kleiner D. Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy. Basic Res Cardiol. 2013;108(4):366.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Li W, Li H, Long Y. Clinical characteristics and long-term predictors of persistent left ventricular systolic dysfunction in peripartum cardiomyopathy. Can J Cardiol. 2016;32:362–8.CrossRefPubMed Li W, Li H, Long Y. Clinical characteristics and long-term predictors of persistent left ventricular systolic dysfunction in peripartum cardiomyopathy. Can J Cardiol. 2016;32:362–8.CrossRefPubMed
13.
Zurück zum Zitat Sliwa K, Skudicky D, Bergmann A, Candy G, Puren A, Sareli P. Peripartum cardiomyopathy: analysis of clinical outcome, left ventricular function, plasma levels of cytokines and Fas/APO-1. J Amcollcardiol. 2000;35(3):701–5.CrossRef Sliwa K, Skudicky D, Bergmann A, Candy G, Puren A, Sareli P. Peripartum cardiomyopathy: analysis of clinical outcome, left ventricular function, plasma levels of cytokines and Fas/APO-1. J Amcollcardiol. 2000;35(3):701–5.CrossRef
14.
Zurück zum Zitat Sliwa K, Förster O, Libhaber E, Fett JD, Sundstrom JB, Hilfiker-Kleiner D, et al. Peripartum cardiomyopathy: inflammatory markers as predictors of outcome in 100 prospectively studied patients. EurHeartJ. 2006;27(4):441–6. Sliwa K, Förster O, Libhaber E, Fett JD, Sundstrom JB, Hilfiker-Kleiner D, et al. Peripartum cardiomyopathy: inflammatory markers as predictors of outcome in 100 prospectively studied patients. EurHeartJ. 2006;27(4):441–6.
15.
Zurück zum Zitat Ijsselmuiden AJ, Musters RJ, de Ruiter G, van Heerebeek L, Alderse-Baas F, van Schilfgaarde M, et al. Circulating white blood cells and platelets amplify oxidative stress in heart failure. Nat Clin Pract Cardiovasc Med. 2008;5(12):811–20. doi:10.1038/ncpcardio1364.CrossRefPubMed Ijsselmuiden AJ, Musters RJ, de Ruiter G, van Heerebeek L, Alderse-Baas F, van Schilfgaarde M, et al. Circulating white blood cells and platelets amplify oxidative stress in heart failure. Nat Clin Pract Cardiovasc Med. 2008;5(12):811–20. doi:10.​1038/​ncpcardio1364.CrossRefPubMed
16.
Zurück zum Zitat Uthamalingam S, Patvardhan EA, Subramanian S, Ahmed W, Martin W, Daley M, et al. Utility of the neutrophil to lymphocyte ratio in predicting long-term outcomes in acute decompensated heart failure. Am J Cardiol. 2011;107(3):433–8.CrossRefPubMed Uthamalingam S, Patvardhan EA, Subramanian S, Ahmed W, Martin W, Daley M, et al. Utility of the neutrophil to lymphocyte ratio in predicting long-term outcomes in acute decompensated heart failure. Am J Cardiol. 2011;107(3):433–8.CrossRefPubMed
17.
Zurück zum Zitat Park JJ, Jang HJ, Oh IY, Yoon CH, Suh JW, Cho YS, et al. Prognostic value of neutrophil to lymphocyte ratio in patients presenting with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Am J Cardiol. 2013;111(5):636–42.CrossRefPubMed Park JJ, Jang HJ, Oh IY, Yoon CH, Suh JW, Cho YS, et al. Prognostic value of neutrophil to lymphocyte ratio in patients presenting with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Am J Cardiol. 2013;111(5):636–42.CrossRefPubMed
18.
Zurück zum Zitat Bauersachs J, Arrigo M, Hilfiker-Kleiner D, Veltmann C, Coats AJ, Crespo-Leiro MG, et al. Current management of patients with severe acute peripartum cardiomyopathy: practical guidance from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy. Eur J Heart Fail. 2016;18(9):1096–105. doi:10.1002/ejhf.586.CrossRefPubMed Bauersachs J, Arrigo M, Hilfiker-Kleiner D, Veltmann C, Coats AJ, Crespo-Leiro MG, et al. Current management of patients with severe acute peripartum cardiomyopathy: practical guidance from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy. Eur J Heart Fail. 2016;18(9):1096–105. doi:10.​1002/​ejhf.​586.CrossRefPubMed
19.
Zurück zum Zitat Hu CL, Li YB, Zou YG, Zhang JM, Chen JB, Liu J, Tang YH, Tang QZ, Huang CX. Troponin T measurement can predict persistent left ventricular dysfunction in peripartum cardiomyopathy. Heart. 2007;93(4):488–90.CrossRefPubMed Hu CL, Li YB, Zou YG, Zhang JM, Chen JB, Liu J, Tang YH, Tang QZ, Huang CX. Troponin T measurement can predict persistent left ventricular dysfunction in peripartum cardiomyopathy. Heart. 2007;93(4):488–90.CrossRefPubMed
20.
21.
Zurück zum Zitat Turfan M, Erdoğan E, Tasal A, Vatankulu MA, Jafarov P, Sönmez O, et al. Neutrophil to lymphocyte ratio and in hospital mortality in patients with acute heart failure. Clinics. 2014;69(3):190–3.CrossRefPubMedPubMedCentral Turfan M, Erdoğan E, Tasal A, Vatankulu MA, Jafarov P, Sönmez O, et al. Neutrophil to lymphocyte ratio and in hospital mortality in patients with acute heart failure. Clinics. 2014;69(3):190–3.CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Amos AM, Jaber WA, Russell SD. Improved outcomes in peripartumcardiomyopathy with contemporary. Am Heart J. 2006;152(3):509–13.CrossRefPubMed Amos AM, Jaber WA, Russell SD. Improved outcomes in peripartumcardiomyopathy with contemporary. Am Heart J. 2006;152(3):509–13.CrossRefPubMed
23.
Zurück zum Zitat Forster O, Hilfiker-Kleiner D, Ansari AA, Sundstrom JB, Libhaber E, Tshani W, et al. Reversal of IFN-gamma oxLDL and prolactinserum level correlate with clinical improvement in patients with peripartum cardiomyopathy. Eur J Heart Fail. 2008;10(9):861–8.CrossRefPubMed Forster O, Hilfiker-Kleiner D, Ansari AA, Sundstrom JB, Libhaber E, Tshani W, et al. Reversal of IFN-gamma oxLDL and prolactinserum level correlate with clinical improvement in patients with peripartum cardiomyopathy. Eur J Heart Fail. 2008;10(9):861–8.CrossRefPubMed
24.
Zurück zum Zitat Kamiya CA, Kitakaze M, Ishibashi-Ueda H, Nakatani S, Murohara T, Tomoike H, Ikeda T. Different characteristics of peripartum cardiomyopathy between patients complicated with and without hypertensive disorders. – Results from the Japanese Nationwide survey of peripartum cardiomyopathy – T. Circ J. 2011;75(8):1975–81.CrossRefPubMed Kamiya CA, Kitakaze M, Ishibashi-Ueda H, Nakatani S, Murohara T, Tomoike H, Ikeda T. Different characteristics of peripartum cardiomyopathy between patients complicated with and without hypertensive disorders. – Results from the Japanese Nationwide survey of peripartum cardiomyopathy – T. Circ J. 2011;75(8):1975–81.CrossRefPubMed
25.
Zurück zum Zitat Safirstein JG, Ro AS, Grandhi S, Wang L, Fett JD, Staniloae C. Predictors of left ventricular recovery in a cohort of peripartum cardiomyopathy patients recruited via the internet. Int J Cardiol. 2012;154:27–31.CrossRefPubMed Safirstein JG, Ro AS, Grandhi S, Wang L, Fett JD, Staniloae C. Predictors of left ventricular recovery in a cohort of peripartum cardiomyopathy patients recruited via the internet. Int J Cardiol. 2012;154:27–31.CrossRefPubMed
26.
Zurück zum Zitat Vázquez Blanco M, Roisinblit J, Grosso O, Rodriguez G, Robert S, Berensztein CS, et al. Left ventricular function impairment in pregnancy-induced hypertension. Am J Hypetens. 2001;14:271–5.CrossRef Vázquez Blanco M, Roisinblit J, Grosso O, Rodriguez G, Robert S, Berensztein CS, et al. Left ventricular function impairment in pregnancy-induced hypertension. Am J Hypetens. 2001;14:271–5.CrossRef
27.
Zurück zum Zitat Rafik Hamad R, Larsson A, Pernow J, Bremme K, Eriksson MJ. Assessment of left ventricular structure and function in preeclampsia by echocardiography and cardiovascular biomarkers. J Hypertens. 2009;27(11):2257–64, Nov.CrossRefPubMed Rafik Hamad R, Larsson A, Pernow J, Bremme K, Eriksson MJ. Assessment of left ventricular structure and function in preeclampsia by echocardiography and cardiovascular biomarkers. J Hypertens. 2009;27(11):2257–64, Nov.CrossRefPubMed
Metadaten
Titel
Value of the neutrophil-to-lymphocyte ratio in predicting left ventricular recovery in patients with peripartum cardiomyopathy
verfasst von
Ufuk Gürkan, MD
Haldun Akgöz, MD
Şukru Aksoy, MD
Özlem Can Gürkan, PhD
Altug Osken, MD
Sennur Unal Dayi, MD
Dilaver Oz, MD
Recep Haci, MD
Publikationsdatum
12.07.2017
Verlag
Springer Vienna
Erschienen in
Wiener klinische Wochenschrift / Ausgabe 23-24/2017
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI
https://doi.org/10.1007/s00508-017-1227-6

Weitere Artikel der Ausgabe 23-24/2017

Wiener klinische Wochenschrift 23-24/2017 Zur Ausgabe

mitteilungen der gesellschaft der ärzte in wien

Veranstaltungen